Clinical Trial Update: Growth Hormone, Cardiovascular Risk, and Visceral Adiposity [NA]

View source ↗

Summary

This update reports the completion of a clinical trial evaluating growth hormone (somatropin) and its impact on cardiovascular risk and visceral adiposity in ob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Obesity | NA | Status: COMPLETED | Results posted: 2014-03-06